Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 05, 2021

BUY
$6.31 - $8.4 $189,300 - $252,000
30,000 New
30,000 $32,000
Q2 2020

Aug 13, 2020

SELL
$4.9 - $6.14 $61,450 - $77,001
-12,541 Closed
0 $0
Q1 2020

May 12, 2020

SELL
$4.63 - $10.62 $28,821 - $66,109
-6,225 Reduced 33.17%
12,541 $75,000
Q4 2019

Jan 28, 2020

SELL
$8.7 - $9.79 $7,177 - $8,076
-825 Reduced 4.21%
18,766 $174,000
Q3 2019

Oct 22, 2019

BUY
$7.2 - $10.2 $28,800 - $40,800
4,000 Added 25.66%
19,591 $182,000
Q2 2019

Jul 18, 2019

BUY
$9.5 - $14.5 $627 - $957
66 Added 0.43%
15,591 $156,000
Q1 2019

May 06, 2019

SELL
$13.83 - $19.63 $214,710 - $304,755
-15,525 Reduced 50.0%
15,525 $217,000
Q1 2019

May 01, 2019

SELL
$13.83 - $19.63 $95,178 - $135,093
-6,882 Reduced 18.14%
31,050 $434,000
Q4 2018

Feb 13, 2019

SELL
$14.15 - $18.99 $281,585 - $377,900
-19,900 Reduced 34.41%
37,932 $605,000
Q3 2018

Nov 14, 2018

SELL
$18.7 - $21.72 $5.99 Million - $6.96 Million
-320,425 Reduced 84.71%
57,832 $1.09 Million
Q2 2018

Aug 14, 2018

BUY
$18.55 - $21.37 $18,141 - $20,899
978 Added 0.26%
378,257 $7.28 Million
Q1 2018

May 18, 2018

BUY
$19.52 - $22.64 $77,748 - $90,175
3,983 Added 1.07%
377,279 $8.06 Million
Q4 2017

Feb 13, 2018

BUY
$16.63 - $21.24 $602,604 - $769,652
36,236 Added 10.75%
373,296 $7.67 Million
Q3 2017

Nov 16, 2017

BUY
$17.43 - $21.51 $344,469 - $425,102
19,763 Added 6.23%
337,060 $6.22 Million
Q2 2017

Aug 15, 2017

BUY
N/A
317,297
317,297 $7.91 Million

Others Institutions Holding PMD

About PSYCHEMEDICS CORP


  • Ticker PMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 5,626,200
  • Market Cap $13.2M
  • Description
  • Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, ...
More about PMD
Track This Portfolio

Track Moors & Cabot, Inc. Portfolio

Follow Moors & Cabot, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Moors & Cabot, Inc. with notifications on news.